Handelsavisen
prelaunch
Companies Healthcare ECOR.BO
EC
ECOR.BO BSE (India) Diversified Medical Equipment & Supplies

Ecor.Bo

$467,50
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
56,3 %
ROE
20,9 %
Net margin
48,0 %
Debt / equity
0,05
Beta
52w range
Volume
3,2k
Day range
$8,65–$9,68
Prev close
$8,91
Open
$8,95
Next earnings
2026-10-28
Ex-dividend
TR 1Y
About

ECOR.BO provides industrial services focused on environmental solutions, including waste management, recycling, and pollution control.

Business. electroCore, Inc. (ECOR.O) is a healthcare services and equipment company that operates within the medical equipment, supplies, and distribution industry. The firm generates revenue primarily through the sale of products. Headquartered in the United States, the company is listed on the NASDAQ stock exchange. Specific operating segments and geographic breakdowns are not disclosed in the available data.

Classification99 %
SectorHealth Care
Industry groupDiversified Medical Equipment & Supplies
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
Geode Capital Management, L.L.C.
largest disclosed fund holder
Profitability
20,9 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning ECOR.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to ECOR.BO. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    electroCore, Inc. (ECOR.O) is a healthcare services and equipment company that operates within the medical equipment, supplies, and distribution industry. The firm generates revenue primarily through the sale of products. Headquartered in the United States, the company is listed on the NASDAQ stock exchange. Specific operating segments and geographic breakdowns are not disclosed in the available data.

    Classification99 %
    SectorHealth Care
    Industry groupDiversified Medical Equipment & Supplies
    AI synthesis
    GENERATED

    ECOR.BO maintains a strong liquidity position with a current ratio of 4.52 and a low debt-to-equity ratio of 0.05, indicating minimal reliance on debt financing and a robust balance sheet. The company's cash and equivalents amount to INR 134.3 million, which supports its operational flexibility and capacity to fund future growth initiatives. The free cash flow of INR 234.1 million further reinforces its ability to reinvest in the business or return value to shareholders.

    In terms of profitability, ECOR.BO demonstrates a return on equity (ROE) of 20.89% and a return on assets (ROA) of 17.16%, both of which exceed the typical thresholds for the environmental services industry. These metrics suggest that the company is effectively utilizing its equity and asset base to generate returns. The operating margin of 56.3% (calculated as operating income of INR 271.2 million divided by revenue of INR 481.8 million) is also strong, indicating efficient cost management and pricing power.

    The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of segmental and geographic diversification may expose the company to localized economic or regulatory risks. However, the environmental services industry is generally less sensitive to macroeconomic cycles, which may provide some insulation.

    Looking ahead, ECOR.BO is projected to experience a significant increase in revenue, with the mean analyst estimate for the next fiscal year at INR 77.25 billion, compared to the actual revenue of INR 481.8 million in the most recent period. This represents a substantial year-over-year growth rate, although the high estimate may reflect optimism about the company's expansion plans or market share gains. The company's capital expenditure of INR -10.6 million suggests a reduction in investment in physical assets, which may indicate a shift toward more efficient operations or a focus on cash preservation.

    The risk assessment for ECOR.BO indicates a low probability of liquidity and dilution risks, with no immediate filing-based flags detected. The company's low debt levels and strong cash position reduce the likelihood of financial distress. Additionally, the absence of dilution risk suggests that the company is not currently issuing new shares to raise capital, preserving shareholder value. The low dilution potential is further supported by the fact that the number of shares outstanding has remained unchanged between basic and diluted shares.

    Recent events, including the latest financial filings and analyst estimates, suggest a positive outlook for ECOR.BO. The company's strong performance in the most recent reporting period, with an actual EPS of INR 22.75 compared to a mean estimate of INR 19.50, indicates that it is outperforming expectations. The consistent price target of INR 720.00 across all analyst estimates also signals confidence in the company's future performance.

    Key takeaways
    • ECOR.BO has a strong liquidity position with a current ratio of 4.52 and a low debt-to-equity ratio of 0.05.
    • The company's ROE of 20.89% and ROA of 17.16% indicate efficient use of equity and assets to generate returns.
    • Revenue is concentrated in a single business segment, with no geographic diversification disclosed.
    • Analysts project a significant increase in revenue for the next fiscal year, with a mean estimate of INR 77.25 billion.
    • The company has a low risk of liquidity and dilution, with no immediate filing-based flags detected.
    • ECOR.BO outperformed EPS estimates in the most recent reporting period, with an actual EPS of INR 22.75.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $467,50
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $1.11B
    Net cash
    $75.8M
    Current ratio
    4.5
    Debt / equity
    0.1
    ROA
    17.2%
    ROE
    20.9%
    Cash conversion
    56.0%
    CapEx / revenue
    -2.2%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    INDUSTRYSEGMENTCOMPANYHealthcareIndustryDiversified Medical Equipment & Supplies259,3B node revenueABT 17,1%MDT 14,0%MDLN 11,0%SYK 9,7%BDX 8,4%HSIC 5,1%BAX 4,3%SOLV 3,2%Other 27,2%
    Source: company disclosures · own-taxonomy revenue-covered set · attribution: collision-suspect (indicative)ECOR 0,0% · rank #64 of 84

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    Peer comparison8 peers · vs ECOR · multiples and returns
    AB
    ABT
    Abbott Laboratories
    $107,13
    187,2B USD
    P/E
    26,3x
    vs self
    Div yield
    2,4 %
    vs self
    ROE
    12,5 %
    -804,7 vs self
    MD
    MDT
    Medtronic PLC
    $86,19
    110,3B USD
    P/E
    21,4x
    vs self
    Div yield
    3,4 %
    vs self
    ROE
    9,7 %
    -807,5 vs self
    MD
    MDLN
    MEDLINE INC.
    $40,47
    53,2B USD
    P/E
    202,6x
    vs self
    Div yield
    vs self
    ROE
    vs self
    SY
    SYK
    Stryker Corp
    $341,20
    131,8B USD
    P/E
    38,0x
    vs self
    Div yield
    vs self
    ROE
    13,5 %
    -803,7 vs self
    BD
    BDX
    Becton Dickinson And Co
    $170,21
    48,4B USD
    P/E
    25,6x
    vs self
    Div yield
    2,8 %
    vs self
    ROE
    7,0 %
    -810,3 vs self
    HS
    HSIC
    Henry Schein Inc
    $88,21
    10,1B USD
    P/E
    80,5x
    vs self
    Div yield
    vs self
    ROE
    3,0 %
    -814,2 vs self
    BA
    BAX
    Baxter International Inc
    $28,10
    14,5B USD
    P/E
    vs self
    Div yield
    2,3 %
    vs self
    ROE
    -15,4 %
    -832,6 vs self
    SO
    SOLV
    SOLVENTUM CORPORATION
    $76,83
    13,3B USD
    P/E
    8,6x
    vs self
    Div yield
    vs self
    ROE
    30,8 %
    -786,4 vs self

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    19,50
    Predicted surprise
    0,00
    Beat probability
    45 %
    Analysts
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-10 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate19,50
    Revenueno estimateno estimate77,2B INR
    Operating incomeno estimateno estimateno estimate
    Full-year consensus mean (period as reported by source) · consensus in INR. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    12-month price target$720,00 · Median $720,00
    Low $720,00High $720,00
    EPS surprise
    +16,7 %
    reported vs consensus · beat
    Revenue surprise
    −99,4 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$720,00
    Mean$720,00
    Median$720,00
    High$720,00
    Spot$467,50
    +54.0 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin56,3 %Best in class
    Net Margin48,0 %Best in class
    ROE20,9 %Above P75
    Capex / Rev-2,2 %Below median
    D/E0,05Above median
    Cash Conv0,56Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    Derivative transactions

    Net acquired 42 055 sh2 exercises1 insiders
    • Errico Thomas J.Director · Warrants to Purchase Common Stock → Common StockAcquired 19 252 @ $6,43exercise · 2026-03-19
    • Errico Thomas J.Director · Warrants to Purchase Common Stock → Common StockAcquired 22 803 @ $4,35exercise · 2026-03-19

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • ECOR.BO Market data — financials · 2026-05-27
    • Eco Recycling Ltd Market data — analyst estimates · 2026-05-27

    Ownership & reference

    Top holders

    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,00 %$0M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,00 %$1M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,00 %$0M
    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,00 %$0M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,00 %$0M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$0M

    Insider activity

    Net selling4 buys · 6 sellsnet -$610K9 insiders · last 365d
    • Lev Joshua S.CFO and Interim President · Common StockSold 6 667 @ $9,00$60K · 2026-05-28
    • Lev Joshua S.CFO and Interim President · Common StockSold 3 000 @ $6,50$20K · 2026-05-22
    • Errico Thomas J.Director · Common StockBought 9 992 @ $5,99$60K · 2026-05-21
    • Errico Thomas J.Director · Common StockOther 8 @ $5,98$48 · 2026-05-20
    • Goldberger Daniel SFormer Officer & Director · Common StockSold 80 000 @ $6,80$544K · 2026-04-23
    • Fox MichaelChief Operating Officer · Common StockOther 70 000 · 2026-04-13
    • Goldberger Daniel SFormer Officer and Director · Common StockSold 16 072 @ $6,02$97K · 2026-04-10
    • Lev Joshua S.CFO and Interim President · Common StockOther 45 000 · 2026-04-01
    • Errico Thomas J.Director · Common StockOther 19 252 @ $6,43$124K · 2026-03-19
    • Errico Thomas J.Director · Common StockOther 22 803 @ $4,35$99K · 2026-03-19
    • Lev Joshua S.Chief Financial Officer · Common StockOther 25 000 · 2026-01-26
    • Goldberger Daniel SDirector, Chief Executive Officer · Common StockOther 20 375 @ $7,47$152K · 2026-01-26
    • Goldberger Daniel SDirector, Chief Executive Officer · Common StockOther 26 000 · 2026-01-26
    • Lev Joshua S.Chief Financial Officer · Common StockOther 2 889 · 2026-01-26
    • Lev Joshua S.Chief Financial Officer · Common StockSold 2 500 @ $5,05$13K · 2025-12-04
    • Goldberger Daniel SDirector, Chief Executive Officer · Common StockBought 1 000 @ $4,84$5K · 2025-12-02
    • Lev Joshua S.Chief Financial Officer · Common StockSold 2 166 @ $6,18$13K · 2025-11-12
    • Bonfiglioli ElenaDirector · Common StockOther 30 549 · 2025-09-10
    • PATTON THOMAS MDirector · Common StockOther 19 011 · 2025-09-02
    • Errico Thomas J.Director · Common StockOther 26 615 · 2025-09-02
    • GANDOLFO JOHN PDirector · Common StockOther 19 011 · 2025-09-02
    • Wilber PatriciaDirector · Common StockOther 19 011 · 2025-09-02
    • Goldstein Julie AnnDirector · Common StockOther 19 011 · 2025-09-02
    • Goldberger Daniel SDirector, Chief Executive Officer · Common StockBought 1 000 @ $4,23$4K · 2025-08-11
    • Errico Thomas J.Director · Common StockBought 15 000 @ $4,47$67K · 2025-08-11

    Short positioning

    367.6Kshares short+80.0% vs prior
    3.45days to cover
    34.8%short of daily vol
    264fails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    ECOR.BOCanonical
    BSE (India) · USD

    Intel & risk

    PredictorBeat prob45 %Surprise0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    • Current ratio (FY 2025-12-31): 1.38xDerived (calculated)
    • Return on assets (FY 2025-12-31): -74.8%Derived (calculated)
    • Return on equity (FY 2025-12-31): 817.2%Derived (calculated)
    • Net margin (FY 2025-12-31): -43.6%Derived (calculated)
    • Gross margin (FY 2025-12-31): 86.8%Derived (calculated)
    • Debt-to-equity (FY 2025-12-31): -11.92xDerived (calculated)
    • Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 90.1%Derived (calculated)
    • Revenue (YoY) (2025-12-31 vs 2024-12-31): 27.2%Derived (calculated)
    • Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -17.8%Derived (calculated)
    • EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): -3.8%Derived (calculated)
    • Operating income (YoY) (2025-12-31 vs 2024-12-31): -8.1%Derived (calculated)
    • Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 12.1%Derived (calculated)
    • EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): -3.8%Derived (calculated)
    • Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 57.6%Derived (calculated)
    • Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -122.7%Derived (calculated)
    • Capex (YoY) (2025-12-31 vs 2023-12-31): -68.0%Derived (calculated)
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): -8.8%Derived (calculated)
    • Gross profit (YoY) (2025-12-31 vs 2024-12-31): 29.9%Derived (calculated)
    • Net income (YoY) (2025-12-31 vs 2024-12-31): -17.5%Derived (calculated)
    • Pre-tax income (annual): USD -13.96MSEC XBRL filing
    • EPS (diluted) (annual): USD-PER-SHARES -2SEC XBRL filing
    • Total operating expenses (annual): USD 40.94MSEC XBRL filing
    • Total liabilities (annual): USD 20.38MSEC XBRL filing
    • Cash & equivalents (annual): USD 7.04MSEC XBRL filing
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-05-28 00:00 UTCINSIDER4 insider transactions — 2026-05 · $139k gross
    2026-05-28INSIDERLev Joshua S. sold 6.7k sh — CFO and Interim President ~$60k
    2026-05-22INSIDERLev Joshua S. sold 3.0k sh — CFO and Interim President ~$20k
    2026-05-21INSIDERErrico Thomas J. bought 10.0k sh — Director ~$60k
    2026-05-20INSIDERErrico Thomas J. transacted 8 sh — Director ~$0k
    2026-05-06FILING10-Q filing →
    2026-05-06FILING8-K filing →
    2026-04-23INSIDERGoldberger Daniel S sold 80.0k sh — Former Officer & Director ~$544k
    2026-04-13 00:00 UTCINSIDER3 insider transactions — 2026-04
    2026-04-13INSIDERFox Michael transacted 70.0k sh — Chief Operating Officer
    2026-04-10INSIDERGoldberger Daniel S sold 16.1k sh — Former Officer and Director ~$97k
    2026-04-01INSIDERLev Joshua S. transacted 45.0k sh — CFO and Interim President
    2026-03-19 00:00 UTCINSIDER4 insider transactions — 2026-03 · net buy $223k 2 derivative
    2026-03-19FILING10-K filing →
    2026-03-19FILING8-K filing →
    2026-03-19INSIDERErrico Thomas J. transacted 19.3k sh — Director ~$124k
    2026-03-19INSIDERErrico Thomas J. transacted 22.8k sh — Director ~$99k
    2026-03-19INSIDERErrico Thomas J. acquired 22.8k sh Warrants to Purchase Common Stock — Director
    2026-03-19INSIDERErrico Thomas J. acquired 19.3k sh Warrants to Purchase Common Stock — Director
    2026-01-26 00:00 UTCINSIDER4 insider transactions — 2026-01 · net buy $152k
    2026-01-26INSIDERLev Joshua S. transacted 25.0k sh — Chief Financial Officer
    2026-01-26INSIDERGoldberger Daniel S transacted 20.4k sh — Director, Chief Executive Officer ~$152k
    2026-01-26INSIDERGoldberger Daniel S transacted 26.0k sh — Director, Chief Executive Officer
    2026-01-26INSIDERLev Joshua S. transacted 2.9k sh — Chief Financial Officer
    2026-01-20FILING8-K filing →
    2025-12-04 00:00 UTCINSIDER2 insider transactions — 2025-12
    2025-12-04INSIDERLev Joshua S. sold 2.5k sh — Chief Financial Officer ~$13k
    2025-12-02INSIDERGoldberger Daniel S bought 1.0k sh — Director, Chief Executive Officer ~$5k
    2025-11-12 00:00 UTCINSIDER1 insider transaction — 2025-11
    2025-11-12INSIDERLev Joshua S. sold 2.2k sh — Chief Financial Officer ~$13k
    2025-11-05FILING10-Q filing →
    2025-11-05FILING8-K filing →
    2025-10-24FILING424B3 filing →
    2025-10-03FILING8-K filing →
    2025-09-10 00:00 UTCINSIDER6 insider transactions — 2025-09
    2025-09-10INSIDERBonfiglioli Elena transacted 30.5k sh — Director
    2025-09-03FILING8-K filing →
    Showing the 40 most recent of 50 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage